Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dice Therapeutics Inc (NQ: DICE )

29.34 +0.67 (+2.34%)
Streaming Delayed Price Updated: 11:52 AM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Dice Therapeutics Inc

DICE Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
From DICE Therapeutics, Inc.
Via Globe NewsWire
DICE Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
From DICE Therapeutics, Inc.
Via Globe NewsWire
DICE Therapeutics Announces Late-Breaking Presentation at the 2023 American Academy of Dermatology (AAD) Annual Meeting
From DICE Therapeutics, Inc.
Via Globe NewsWire
DICE Therapeutics to Participate at Upcoming Investor Conferences
From DICE Therapeutics, Inc.
Via Globe NewsWire
DICE Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From DICE Therapeutics, Inc.
Via Globe NewsWire
DICE Therapeutics Reports Third Quarter 2022 Financial Results and Recent Highlights
From DICE Therapeutics, Inc.
Via Globe NewsWire
DICE Therapeutics to Present at Upcoming Investor Conferences
From DICE Therapeutics, Inc.
Via Globe NewsWire
DICE Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
From DICE Therapeutics, Inc.
Via Globe NewsWire
DICE Announces Pricing of Upsized Public Offering of Common Stock
From DICE Therapeutics, Inc.
Via Globe NewsWire
DICE Announces Proposed Public Offering of Common Stock
From DICE Therapeutics, Inc.
Via Globe NewsWire
DICE Therapeutics Announces Positive Topline Data from Phase 1 Clinical Trial of Lead Oral IL-17 Antagonist, DC-806, for Psoriasis
From DICE Therapeutics, Inc.
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.